Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
収録刊行物
-
- Nature Communications
-
Nature Communications 5 (1), 5694-, 2014-12-02
Springer Science and Business Media LLC